11th Annual Women and Ischemic Heart Disease Symposium

REGISTRATION IS NOW CLOSED. ON-SITE REGISTRATION WILL BE AVAILABLE.

Meeting Location:
Cedars-Sinai Medical Center
Harvey Morse Conference Center
8701 Gracie Allen Drive
Los Angeles, CA, 90048

Parking:
Self parking is available in the visitor parking lots P1, P2 (George Burns Road) or P4 (Sherbourne Drive) for a daily rate of $10.00.
Parking at peak times is limited; please arrive early to ensure adequate time to park.

Click Here to view campus map.

This in depth educational symposium will explore gender specific issues in prevalence, risk factors, screening modalities, and medical management strategies, including antiatherosclerotic preventive management, symptom management, hypertension, cholesterol, hormone therapy, STEMI, resorbable stents, heart failure, statin intolerance, and coronary microvasculary dysfunction. The purpose of this conference is to close the knowledge gap of physicians and allied health care professionals regarding sex-specific differences in cardiovascular disease, the impact these differences have on treatment options, and to highlight the importance of identifying women at risk for cardiovascular disease by utilizing the most current evidence-based treatment strategies for improved patient outcomes.

Earn up to 7.0 AMA PRA Category 1 Credits™

1. Describe how clinical manifestations of cardiovascular disease vary in women
2. Recognize risk factors and the role genes, hormones and life circumstances play in CVD
3. Focus clinical practice approach on the unique aspects of cardiovascular care for women to provide necessary resources for prevention, diagnosis and treatment of CVD in women
4. Develop a genderspecific approach to the identification and diagnosis of obstructive disease in women
5. Review results of the latest clinical trials to understand the benefits of CRT and ICD therapies in patients with heart failure and reduced ejection fraction
6. Review results of latest clinical trials to understand the sex differences and/or data in efficacy in women with the new resorbable stents
7. Identify statin intolerance risks in females
8. Recognize the benefits and guidelines to utilizing PSCK9 inhibitors to achieve reductions in LDL cholesterol in women with statin intolerance
9. Review results of SPRINT Trial specific to women in order to understand and examine clinical implications for management of hypertension in female and in the elderly

REGISTRATION IS NOW CLOSED. ON-SITE REGISTRATION WILL BE AVAILABLE.

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation Statement
Cedars-Sinai Medical Center designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Friday, May 12, 2017